Thank you for your interest in providing feedback to FDA during the public meeting on the Generic Drug User Fee Amendments (GDUFA) reauthorization.
If you would like to request time to make an oral statement during the public comment session, please fill out this form. You must complete the form by 11:59 p.m. Eastern Time on September 3, 2026 for your request to be considered.
FDA will determine the amount of time allotted to each commenter, the approximate time each comment is to begin, and will plan to select and notify participants by September 10, 2026. We will do our best to accommodate requests to make public comments. Individuals and organizations with common interests are urged to consolidate or coordinate their comments and request time jointly.